Narcolepsy Type 1 Studies

We are currently enrolling into a study for subjects narcolepsy type 1 with the following criteria:

Narcolepsy Study (Lower sodium-sodium oxybate):

  • 18-week main study
  • Optional 24-week open label extension study
  • Placebo controlled
  • History of >14 cataplexy attacks in 2-week period on average
  • 18-70 years of age
Share